Library
25T-2-NBOMe
25T-2-NBOMe is a highly potent NBOMe derivative active in the microgram range. This compound is the N-(2-methoxybenzyl) derivative of 2C-T-2 and exhibits significantly increased potency compared to its parent compound. Accurate measurement with a 0.001 g (milligram) scale or volumetric dosing is essential; visual dosing is extremely dangerous and responsible for most NBOMe hospitalisations and fatalities. Acute risks include peripheral vasoconstriction, hypertension, tachycardia, hyperthermia, agitation, and seizures at high doses. Several fatalities have been reported within the NBOMe series from dose confusion and insufflation.
Also known as: 2c-t-2-nbome, NBOMe-2C-T-2
Classification
- Chemical: Phenethylamine
- Psychoactive: Psychedelic
- Tag: Hallucinogen
- Tag: Research-Chemical
- Tag: Tentative
Effects
- Stimulation
- Vasoconstriction
- Nausea
- Mouth Numbing
- Increased Heart Rate
- Temperature Regulation Suppression
- Mild Euphoria
- Time Distortion
- Analysis Enhancement
- Anxiety
- Confusion
- Euphoria
- Synaesthesia
- Visual Enhancement
- Color Enhancement
- Pattern Recognition Enhancement
- Visual Geometry
- Drifting
Routes of Administration
Sublingual
Dosage
- Threshold: 50 ug
- Light: 100-300 ug
- Common: 300-600 ug
- Strong: 600 £ 1 000 µg
- Heavy: 600 ug
Duration
- Onset: 0.25-0.75 h
- Comeup: 0.5-1 h
- Peak: 1-3 h
- Offset: 3-6 h
- After Effects: 2-10 h
- Total Duration: 4-11 h
Buccal
Dosage
- Threshold: 50 ug
- Light: 100-300 ug
- Common: 300-600 ug
- Strong: 600 £ 1 000 µg
- Heavy: 600 ug
Duration
- Onset: 0.25-0.75 h
- Comeup: 0.5-1 h
- Peak: 1-3 h
- Offset: 3-6 h
- After Effects: 2-10 h
- Total Duration: 5-10 h
Insufflated
Dosage
- Threshold: 25 ug
- Light: 50-200 ug
- Common: 200-400 ug
- Strong: 400-600 ug
- Heavy: 600-800 ug
Duration
- Onset: 0.08-0.25 h
- Comeup: 0.25-0.5 h
- Peak: 0.5-2 h
- Offset: 3-6 h
- After Effects: 2-10 h
- Total Duration: 3-8 h
Harm Reduction
Check interactions before mixing substances, pay attention to dose spacing and hydration, and treat all dosage guidance as approximate rather than guaranteed safe.
Sources
Substance data is aggregated from the following public harm-reduction and reference sources.
Links
This static page is intended as a readable non-JS and prerender-friendly library export.
